Industry update Psilocybin’s anti-depressant effects don’t require the high Pairing the psychedelic substance with a serotonin blocker could greatly expand its clinical use, according to new research from the University of Pittsburgh. Natalia Buendia CalvilloApril 14, 2021
Industry update Psilocybin gives you good ideas, but not when you’re high New research suggests that magic mushrooms can enhance your ability to spontaneously generate creative insights Natalia Buendia CalvilloApril 13, 2021
Industry update Australia to spend $14.5M on psychedelic drug trials Australia is funding research to see if magic mushrooms and ecstasy can treat depression and PTSD Jared GnamMarch 17, 2021
Medical and Pharmaceutical Nature amplifies therapeutic effects of psychedelics: study A recent review suggests natural settings and activities can complement all stages of psychedelic-assisted therapy Natalia Buendia CalvilloFebruary 23, 2021
Industry update CaaMTech close to winning patent to combine weed and psychedelics The Washington State-based biotech startup's application covers a range of cannabinoids and psilocybin compounds Jared GnamFebruary 10, 2021
Canada Proposed amendment could greatly expand access to psychedelic therapy in Canada Proposed by Health Canada, the change would allow patients to access restricted substances like MDMA through the Special Access Program Natalia Buendia CalvilloJanuary 28, 2021
Psychedelics 2020’s top 5 advancements in psychedelics With major research, legal reform, and more than 20 firms going public, it was major year for the re-emerging field Jared GnamDecember 30, 2020
Industry update MagicMed attracts investors to advance library of psychedelic derivatives After raising $8.1M, the Calgary company filed 12 patents and launched a candidate selection program for novel psychedelic mental health treatments Jared GnamDecember 23, 2020
Analysis What happened to Canada’s ibogaine clinics? Following a surge of interest, ibogaine therapy in the country disappeared. But recent signs show regulators are warming to the promising plant Suzannah WeissDecember 23, 2020
Industry update Mydecine to make first legal import of psilocybin mushrooms into Canada Canada continues to open the door for clinical research the effectiveness of psilocybin for mental health treatments Jared GnamDecember 11, 2020